20
Participants
Start Date
October 31, 2009
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
ranibizumab
"Group 1 - 0.5mg intravitreal injection every month for 3 months then as needed for 12 months~Group 2 -0.5mg intravitreal injection every month for 6 months then as needed for 12 months"
California Pacific Medical Center, San Francisco
Stanford University School of Medicine, Stanford
Collaborators (1)
Genentech, Inc.
INDUSTRY
California Pacific Medical Center
OTHER
Pacific Eye Associates
OTHER
Steven R. Sanislo
OTHER